New Treatment Option for Metastatic Hormone-Sensitive Prostate Cancer
Returning guest, Nelson Ambrogio, Senior Vice President and General Manager Oncology, Bayer Pharmaceuticals US, discusses the FDA approval of NUBEQA ® ...
5346 articles
Returning guest, Nelson Ambrogio, Senior Vice President and General Manager Oncology, Bayer Pharmaceuticals US, discusses the FDA approval of NUBEQA ® ...
Over three million adults in America are affected by bipolar I disorder. Learn more on Health Professional Radio.
Michelle Slater, PhD, discusses her forthcoming book, "Starving to Heal in Siberia: My Radical Recovery from Late-Stage Lyme Disease and How It Could He...
Olga is a special education teacher from California living with a rare, inherited, rapidly progressive disease called hereditary ATTR amyloidosis, also ...
Stein, Hematologic Oncologist at Memorial Sloan Kettering Cancer Center discusses the current state of acute myeloid leukemia (AML), the importance of t...
Ronan Rogers, Senior R&D Director at Medtronic discusses the newest drug-eluting coronary stent, the Onyx Frontier™ drug-eluting stent (DES).
John Pandolfino, M.D., Chief of Gastroenterology and Hepatology at Northwestern Medicine discusses the importance of identifying the causes of GERD and ...
Gregg Sylvester, Chief Health Officer at CSL Seqirus, one of the world’s largest influenza providers, discusses the CDC’s Advisory Committee on Imm...
Jamin Brahmbhatt, a board-certified urologist and co-author of a recent consensus statement on saw palmetto extract published in the journal "Uro" discu...
Kyle Kiser, CEO of Arrive Health, a technology partner for health systems, pharmacies, and insurers that provides drug pricing and insurance coverage da...